1. Guest, the two part 'News in Brief' for the week beginning 20th March 2023 is here.
    Dismiss Notice
  2. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

phase iii

  1. cassava7
    Thread

    A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of CFS, Strayer et al, 2012

    Background Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a severely debilitating disease of unknown pathogenesis consisting of a...
    Thread by: cassava7, Jul 28, 2022, 15 replies, in forum: ME/CFS research
Showing results 1 to 1 of 1